Alain Schaffter
Director of Finance/CFO en BACHEM HOLDING AG .
Fortuna: 62 352 $ al 31/03/2024
Perfil
El Sr. Alain Schaffter es Director Financiero de Bachem Holding AG y Director Financiero de Solvias AG.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
31/12/2022 | 650 ( 0.00% ) | 62 352 $ | 31/03/2024 |
Cargos activos de Alain Schaffter
Empresas | Cargo | Inicio |
---|---|---|
BACHEM HOLDING AG | Director of Finance/CFO | 01/02/2021 |
Antiguos cargos conocidos de Alain Schaffter.
Empresas | Cargo | Fin |
---|---|---|
SPEXIS AG | Director of Finance/CFO | - |
PricewaterhouseCoopers AG (Zurich)
PricewaterhouseCoopers AG (Zurich) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers AG provides assurance, tax and advisory services. The company is headquartered in Zurich, Switzerland. | Comptroller/Controller/Auditor | - |
ACINO HOLDING AG | Director of Finance/CFO | - |
Solvias AG
Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Director of Finance/CFO | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
BACHEM HOLDING AG | Health Technology |
SPEXIS AG | Health Technology |
Empresas privadas | 3 |
---|---|
Acino International AG
Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
PricewaterhouseCoopers AG (Zurich)
PricewaterhouseCoopers AG (Zurich) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers AG provides assurance, tax and advisory services. The company is headquartered in Zurich, Switzerland. | Commercial Services |
Solvias AG
Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Alain Schaffter